Search company, investor...
Search
Compass Therapeutics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

compasstherapeutics.com

Founded Year

2014

Stage

Reverse Merger | IPO

Total Raised

$132.58M

Market Cap

0.25B

About Compass Therapeutics

Compass Therapeutics, formerly Kairos Biologics Foundation, is comprehensively drugging the tumor-immune synapse with human antibodies against cell surfaces and soluble targets.

Compass Therapeutics Headquarters Location

245 First Street 3rd Floor

Cambridge, Massachusetts, 02142,

United States

617-500-8099

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Compass Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Compass Therapeutics is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Compass Therapeutics Patents

Compass Therapeutics has filed 21 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/13/2019

6/29/2021

Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies, Experimental cancer drugs

Grant

Application Date

11/13/2019

Grant Date

6/29/2021

Title

Related Topics

Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies, Experimental cancer drugs

Status

Grant

Latest Compass Therapeutics News

Compass Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference

Sep 9, 2022

About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at  https://www.compasstherapeutics.com . Investor Contact

Compass Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Compass Therapeutics Rank

  • When was Compass Therapeutics founded?

    Compass Therapeutics was founded in 2014.

  • Where is Compass Therapeutics's headquarters?

    Compass Therapeutics's headquarters is located at 245 First Street, Cambridge.

  • What is Compass Therapeutics's latest funding round?

    Compass Therapeutics's latest funding round is Reverse Merger.

  • How much did Compass Therapeutics raise?

    Compass Therapeutics raised a total of $132.58M.

  • Who are the investors of Compass Therapeutics?

    Investors of Compass Therapeutics include Olivia Ventures, F-Prime Capital, OrbiMed Advisors, Borealis Ventures, Alexandria Venture Investments and 13 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.